| Name |
Description |
| SB–431542 |
Potent & selective inhibitor of ALK receptors |
| XK469 |
Selective Topoisomerase II-β Inhibitor |
| 3-deaza-cADPR (PDF) |
Potent, heat stable and hydrolysis-resistant cADPR analog |
| ABT 418 |
Novel neuronal nicotinic acetylcholine receptor agonist |
| AL-8810 (PDF) |
A potent and selective FP prostanoid receptor antagonist |
| BW 245C |
Potent, selective prostanoid DP receptor agonist (PDF) |
| BW A868C |
DP prostanoid receptor antagonist (PDF) |
| CGP7930 and CGP13501 |
Novel positive allosteric GABAB receptor modulators (PDF) |
| CNS 1102 |
NMDA receptor antagonist with neuroprotective activity |
| GW2974 |
EGRF / erb-2 tyrosine kinase inhibitor (PDF) |
| L-685,458 |
Potent, selective cell-permeable g-secretase inhibitor |
| MJ 33 |
Active site-directed specific phospholipase A2 inhibitor (PDF) |
| MRS 1754 |
A selective A2B adenosine receptor antagonist |
| MRS 2395 |
P2Y12 Receptor Antagonist |
| NSC 95397 |
A potent and selective irreversible inhibitor of Cdc25 dual specificity phosphatases. |
| p38 MAPK |
Tools for Phosphorylation Research |
| NTF2 |
Nuclear Transport Factor 2 |
| SB 202190 |
Potent, selective, cell permeable inhibitor of p38 MAP kinase |
| SB 366791 |
Potent and selective vanilloid receptor-1 antagonist (PDF) |
| SCH 28080 |
A potent inhibitor of gastric H+, K+-ATPase |
| SR2640 |
Selective CysLT1 leukotriene receptor antagonist. |
| SR 59230A |
The first commercially available selective B3 -adrenoceptor antagonist |
| b-Amyloid ELISA |
Tools for Alzheimer's Disease Research |
| Anti-Amyloid Peptide b |
Tools for Alzheimer's Disease Research |
| Angiostatin |
Endogenous Inhibitors of Angiogenesis |
| Antibodies to Histone Deacetylase |
Valuable tools for scientists working on chromatin remodeling |
| Antibodies to Myosin |
Tools for synaptic vesicle and intracellular organelle trafficking (PDF) |
| BioPORTER® QuikEase™ Protein Delivery Kits |
For intercellular signaling, cell cycle regulation, apoptosis control, & more! |
| Bistratene A |
A potent and selective PKCd activator (PDF) |
| Chymase |
Key Mediator in Cell Signaling Pathways |
| Cinalukast |
Subtype selective, orally active, cysteinyl leukotriene (CysLT1) receptor antagonist |
| Citalopram |
Selective serotonin reuptake inhibitor |
| Dephostatins |
Selective, potent and stable tyrosine phosphatase inhibitors |
| Isradipine |
Potent, selective L-type voltage gated calcium channel blocker |
| Mibefradil |
The first selective T-type calcium channel antagonist (PDF) |
| Neuronal Nitric Oxide Synthase (nNOS) Inhibitors |
Potent peptidomimetic isoform-selective inhibitors of nNOS |
| Nerve Terminal Stain Kits |
For the detection and study of synaptic vesicle recycling in neuronal synapses and neuromuscular junctions |
| NeuroPORTER |
The FAST, RELIABLE method for transfection of neuronal cells |
| PPAR Agonists |
Peroxisome Proliferator-Activated Receptor Agonists |
| PPARs |
Choreographers of metabolic gene transcription (PDF) |
| PPT |
First potent, selective ERa estrogen receptor agonist |
| Panorama Ab Microarray |
Antibody Microarray, 224 Cell Signaling Antibodies |
| Retinoblastoma |
Tools for Apoptosis and Phosphorylation Research |
| Anti-ROC1 |
Antibody to RING-BOX 1 finger protein: An important regulator of protein ubiquitination |
| Tetanus toxin |
Useful tools for mapping the central nervous system (PDF) |
| Serotonin VER3323 |
A novel, orally active 5-HT2C/2B serotonin receptor agonist that reduces food intake |
| Ubiquitin |
Tools for intracellular protein degradation (PDF) |
| Vanilloids |
Vanilloid Receptor Research Tools |
